ToolGen Past Earnings Performance
Past criteria checks 0/6
ToolGen's earnings have been declining at an average annual rate of -174.5%, while the Biotechs industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 64.7% per year.
Key information
-174.5%
Earnings growth rate
-173.2%
EPS growth rate
| Biotechs Industry Growth | 11.7% |
| Revenue growth rate | 64.7% |
| Return on equity | -234.8% |
| Net Margin | -4,357.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How ToolGen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,070 | -46,637 | 13,040 | 7,293 |
| 31 Mar 24 | 1,076 | -43,503 | 10,971 | 6,740 |
| 31 Dec 23 | 1,103 | -42,340 | 10,401 | 6,747 |
| 30 Sep 23 | 1,003 | -15,464 | 11,487 | 5,914 |
| 30 Jun 23 | 650 | -16,988 | 12,604 | 5,851 |
| 31 Mar 23 | 676 | -17,476 | 12,870 | 5,979 |
| 31 Dec 22 | 743 | -18,177 | 13,051 | 6,296 |
| 30 Sep 22 | 817 | -18,686 | 12,137 | 7,354 |
| 30 Jun 22 | 952 | -19,031 | 12,936 | 6,598 |
| 31 Mar 22 | 1,459 | -21,389 | 16,057 | 5,924 |
| 31 Dec 21 | 1,597 | -20,692 | 15,629 | 5,448 |
Quality Earnings: A199800 is currently unprofitable.
Growing Profit Margin: A199800 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A199800's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare A199800's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A199800 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (6.1%).
Return on Equity
High ROE: A199800 has a negative Return on Equity (-234.82%), as it is currently unprofitable.